See the full story in the original article.
Keywords
tariffsCanadaUSDCADmidterm elections
Open a keyword to see other news on the same topic.
Related tickers and likely impact
SPY
▲ Likely positiveSPDR S&P 500 ETF
Relevance: low
| Market | US stocks |
|---|---|
| Sector | ETF |
| Close on 10/22/2026 | 763.96 |
| Change that session | -1.18% |
USD/CAD
▼ Likely negativeRelevance: low
| Market | Currencies |
|---|---|
| Close on 10/22/2026 | 1.40091 |
| Change that session | -0.28% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Trump Lifts Tariffs on Some Canadian Products
President Trump signed an order on Oct. 23 removing the 50% tariff on some Canadian agriculture and forestry products, including plywood, certain paper products, refrigeration equipment, packaging boxes and fresh or dried seaweed, effective Oct. 30, four days before the Nov. 3 midterm elections. To offset this, he added items such as carpets, paint, air conditioners and canoes to the 50% tariff list. The move aims to gain political advantage in Maine, where Republican Senator Susan Collins is in a close race, while Democratic Senator Ron Wyden said it shows American voters are turning against tariff policies. The change follows an August 50% tariff on $20 billion of Canadian imports after bilateral talks collapsed, which Canada answered with 15–50% tariffs on $20 billion of U.S. goods; Canadian minister Dominic LeBlanc said Ottawa is evaluating the latest changes.
- PBO trims economic forecast for 2026 and 2027 amid new U.S. tariffs
The Parliamentary Budget Office cut its real GDP growth forecast to 0.9% for 2026 and 1.5% for 2027, down from 1.1% and 1.6% projected in June. Parliamentary budget officer Annette Ryan said Canada faces a tougher economic and fiscal outlook after new U.S. tariffs and Canadian countermeasures followed the breakdown of trade talks at the end of August. The PBO now projects a $63.3 billion deficit in fiscal 2026-27, peaking at $70.2 billion in 2027-28, with deficits averaging $3 billion a year higher than its June outlook as new spending more than offsets stronger revenues. It assumes the Bank of Canada will start raising its policy rate in early 2027, reaching 2.75% by midyear, and expects inflation to average 2.8% in 2026 before easing to 2.4% in 2027.
- Trump sued over 50% tariffs on Canada in latest trade challenge
A lawsuit filed Tuesday in the U.S. Court of International Trade challenges President Donald Trump's use of Section 338 of the 1930 Tariff Act to impose 50% tariffs on Canadian goods such as hockey sticks, wine, honey, and wigs, imposed in July. Plaintiff Gellert Global Group, a New Jersey food importer whose cheeses are covered by the duties, argues the 96-year-old law was impliedly repealed by later legislation. The complaint asks the court to declare the tariffs unlawful, block their enforcement, and order refunds with interest for duties already paid. Represented by the Liberty Justice Center, which previously helped get the Supreme Court to strike down Trump's reciprocal tariffs in February, the case comes as the administration refunds an estimated $166 billion collected under those duties. The White House did not immediately respond to CNBC's request for comment.
- Bank of Canada Finds Business Sentiment Weakened After U . S . Trade Talks Failed
The Bank of Canada's business outlook survey, published Oct. 19, drew on interviews from Aug. 6 to Sept. 2, most of which were completed before U.S. trade talks failed on Aug. 21. Later responses showed a setback, with firms expecting weaker export sales and feeling less confident about their prospects, as new U.S. tariffs, Canadian counter-tariffs and higher oil prices weighed on outlooks. About half the surveyed firms planned to pass on at least some cost increases linked to tariffs and the Middle East conflict, while hiring plans stayed subdued. Statistics Canada reported consumer prices rose 3.1% in September from a year earlier, up from 3.0% in August, and the central bank kept its overnight rate at 2.25% with its next decision due Oct. 28.
- Sentiment improved , but new tariffs weigh on business outlook : BoC report
- Sentiment improved , but new tariffs weigh on business outlook : BoC report
Related markets
Latest news
- Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying: the iShares Biotechnology ETF (IBB) is up 24% through October 23, after a 28% gain in 2025, with two dozen of its 233 holdings more than doubling year-to-date. Moderna leads with a 587% surge, though its stock fell 18% after a leak of positive cancer-vaccine trial data. Analysts attribute the rally to clinical trial results, M&A, and technologies such as mRNA, genomics and AI, with about a dozen novel biologics approved by the FDA in 2025 out of 46 approvals and roughly 66 novel drugs in the pipeline. The Moderna–Merck melanoma drug showed a 42% reduction in recurrence or death when combined with Keytruda in Phase 3 and is targeted for FDA submission and launch in 2027. Gene-sequencing firm Illumina more than doubled this year, and 10x Genomics rose more than 300%.
- SpaceX's "Super Intelligence" Segment Just Made the Stock a Must-Own
SpaceX's 'super intelligence' (SI) segment, formerly its AI business, generated $7.56 billion in Q3 revenue, up 830% from $813 million in 2025 and well above $2.56 billion in Q2. Most of the growth came from AI models, including subscription platforms, and infrastructure, which rose from $2.56 billion to $7.02 billion; X ad revenue grew from $454 million to $538 million. The segment's capital expenditures reached $16.4 billion in the quarter. The author views the stock as attractively priced at current levels if growth continues, but argues that such a pace may be hard to sustain, and the stock gave back its roughly 10% post-earnings gain by Thursday.
- Top Blockchains Continue to See Rapid Growth in AI Agent Payments. This Is the 1 Crypto You Need to Buy Right Now.
Chainalysis reported 138.5 million payments on Base using x402, a payment protocol built for AI agents, up from 58,800 transactions as of Q3 2025. Over 87% of x402 transactions were between $0.0001 and $0.10, sizes too small for traditional networks like Visa and Mastercard because of fees and chargeback risk. Solana ranks second in x402 volume, has overtaken Base in daily activity at several points this year, and launched batch settlement, which BlockRunAI says saves more than $20,000 a month in fees. However, TRM Labs counted $52.7 million across 198.9 million settlements since March 2025, with about $25.6 million plausible after removing suspicious activity, so agent payments are not yet driving much economic activity. Solana's stablecoin supply hit a record $17.3 billion in September, and the token trades about 64% below its January 2025 high of $293.
- 5 of the Fastest-Growing Stocks in the Market
The article ranks five fast-growing stocks by latest-quarter revenue growth: Nebius Group (NBIS), CoreWeave (CRWV), AppLovin (APP), Robinhood Markets (HOOD) and IREN (IREN), and examines what investors are paying for that growth. Nebius's second-quarter revenue jumped 454% year over year to $582.3 million, but at a price-to-sales ratio (P/S) of about 46, the highest of the five, its growth is largely funded by cash, customer prepayments and outside financing. CoreWeave's revenue rose 112.5% to around $2.6 billion, backed by a $104 billion revenue backlog, and it trades at 6.0 times sales, but $640 million in net interest expense means its growth relies heavily on debt. AppLovin grew revenue 53% to $1.9 billion, funded by its own profits and cash, at about 16 times sales, while Robinhood's revenue rose 32% to a record $1.3 billion at about 23 times sales, though trading activity can fall sharply when markets cool. IREN's total revenue fell 26.7% to $137.2 million as Bitcoin mining declined, while AI cloud revenue grew tenfold to $70.5 million at about 19 times sales; the article suggests AppLovin could be the safest option because its growth is funded by profits.
- Down Roughly 50% From Its Highs, Is Netflix Stock Finally a Buy?
Netflix (NFLX) shares have fallen roughly 50% from their all-time closing high of $133.91 on June 30, 2025, following the company's third-quarter report. Before the report, Netflix fired its chief content officer and announced its largest layoff since 2022, hiring former Disney executive Peter Rice as it struggled to produce U.S. blockbuster shows. In Q3, revenue rose 12% to $12.87 billion and adjusted EPS jumped 49% to $0.87, above the $0.82 analyst estimate compiled by LSEG. Netflix guided Q4 revenue to $13.4 billion but trimmed full-year revenue to $51.1 billion and cut its ad revenue forecast from $3 billion to $2.7 billion due to a slower ad rollout. The article argues that at a forward P/E of about 17 times 2027 estimates, the valuation now looks attractive.
- Meta Just Unveiled a New Takeover Weapon — But There's a Catch
Meta Platforms plans to create a non-voting Class C share class that it could use to raise capital, pay employees and acquire companies as it spends heavily on AI. Shareholders will receive one Class C share for each Class A and Class B share through a one-time dividend, effective January 19, 2027. According to the SEC filing, the structure preserves CEO Mark Zuckerberg's control: he holds about 60.6% of the vote while owning roughly 13.4% of the company, and he can sell 20% of his new Class C shares right away. The filing flags two drawbacks: Class C shares are expected to trade at a discount to voting stock, which would cause more dilution for existing holders, and they cannot meet the voting-stock requirements for certain tax-deferred deals. Meanwhile, third-quarter capex of $34.91 billion left free cash flow at negative $2.12 billion, and Meta expects 2026 capex of $135 billion to $145 billion.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.